FBInvestor
Funds / Trails Edge Capital Partners, LP
Institutional Fund

Trails Edge Capital Partners, LP

Atlanta, GACIK 20772472 filings on record

Portfolio Value
$424.90M
Q1 2026
Holdings
26
Reported positions
New Buys
12
Opened this quarter
QoQ Change
+5.0%
from $404.74M

Portfolio Value Trend

Reported 13F value by quarter

Portfolio value trend — upgrade to see history

Upgrade

Top Allocations

Largest positions by weight

  • Vaxcyte Inc9.1%
  • Definium Therapeutics Inc7.7%
  • Lb Pharmaceuticals Inc7.7%
  • Mirum Pharmaceuticals Inc7.2%
  • Nurix Therapeutics Inc6.4%
  • Xenon Pharmaceuticals Inc6.0%
  • Other55.9%

Portfolio Holdings

26 positions · Q1 2026

#SecuritySharesValue% Port.Δ SharesActivity
1Vaxcyte Inc662.5K$38.50M9.1%75.0KReduced
2Definium Therapeutics Inc1.74M$32.85M7.7%+1.74MNew
3Lb Pharmaceuticals Inc1.32M$32.54M7.7%76.2KReduced
4Mirum Pharmaceuticals Inc333.3K$30.79M7.2%+301.4KAdded
5Nurix Therapeutics Inc1.74M$27.02M6.4%0Held
6Xenon Pharmaceuticals Inc440.0K$25.59M6.0%157.1KReduced
7Revolution Medicines Inc245.0K$23.83M5.6%+245.0KNew
8Arcus Biosciences Inc1.05M$22.64M5.3%+131.6KAdded
9Immunocore Hldgs PLC682.6K$20.58M4.8%0Held
10Cytokinetics Inc300.0K$19.77M4.7%+300.0KNew

16 more holdings on Premium

See this fund's complete portfolio, full position changes, and activity history.

Unlock full portfolio